Fund Overview
ETF
Aditya Birla Sun Life Nifty Healthcare ETF
Ticker: HEALTHYUnderlying Index: Nifty HealthcareISIN: INF209KB10C2
17.0013.16% (1Y)
End of Day NAV as on Sep 10, 2026
Fundamentals
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 20 Companies |
| Market Cap Focus | Large & Mid Cap |
| Std Deviation (1 yr) | 0.85% |
| P/E | 53.97 |
| P/B | 8.28 |
| Div Yield | 0.50% |
| Down from 52w High | 3.78% |
| Up from 52w Low | 25.20% |
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 20 |
| Market Cap Focus | Large & Mid Cap |
| P/E | 53.97 |
| P/B | 8.28 |
| Div Yield | 0.50% |
| Down from 52w High | 3.78% |
| Up from 52w Low | 25.20% |
| Std Deviation (1 yr) | 0.85% |
Fund Parameters
| AUM (Cr) | 82 |
| Base Expense Ratio | 0.16% |
| Tracking Error | 0.01% |
| All-In-Cost | 0.17% |
| Inception Date | 21 Oct 2021 |
| Scheme Option - Type | Growth - Open ended scheme |
| Latest Price | 17.00 |
| NAV Gap | -0.01% |
| 1M Average NAV Gap | -0.13% |
| Daily Volume | 1,82,029 |
| 1M Average Daily Volume | 2,48,354 |
| 1M Average Daily Turnover (Cr) | 0.4 |
Native Score
| AUM (Cr) | 82 |
| Base Expense Ratio | 0.16% |
| Tracking Error | 0.01% |
| All-In-Cost | 0.17% |
| Inception Date | 21 Oct 2021 |
| Scheme Option - Type | Growth - Open ended scheme |
| ETF Market Data | |
| Latest Price | 17.00 |
| NAV Gap | -0.01% |
| 1M Avg NAV Gap | -0.13% |
| Daily Volume | 1,82,029 |
| 1M Avg Daily Volume | 2,48,354 |
| 1M Avg Daily Turnover | 0.4 |
| Native Score | |
Similar Exchange Traded Funds (ETFs)
| Fund Name | ||||||||
|---|---|---|---|---|---|---|---|---|
| 169.47 | 221 | 0.13% | 0.01% | 1 | -0.06% | 0.14% | ||
| 168.13 | 24 | 0.33% | 0.01% | 0 | -0.06% | 0.34% | ||
| 16.66 | 17 | 0.17% | 0.01% | 0 | N/A | 0.18% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | 1M ADTO (Cr) | 1M Avg NAV Gap | All-In-Cost | Score |
|---|---|---|---|---|---|---|---|---|
| 169.47 | 221 | 0.13% | 0.01% | 1 | -0.06% | 0.14% | ||
| 168.13 | 24 | 0.33% | 0.01% | 0 | -0.06% | 0.34% | ||
| 16.66 | 17 | 0.17% | 0.01% | 0 | N/A | 0.18% |
Similar Index Funds
| Fund Name | ||||||
|---|---|---|---|---|---|---|
| N/A | 22 | 0.21% | 0.04% | 0.25% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | All-In-Cost | Score |
|---|---|---|---|---|---|---|
| N/A | 22 | 0.21% | 0.04% | 0.25% |
Sectoral Allocation
Total
100%
allocation
- Healthcare99.2%
- Business Services0.6%
- Miscellaneous0.5%
- Healthcare99.2%
- Business Services0.6%
- Miscellaneous0.5%
Fund Holdings
| Name | Weight |
|---|
| Sun Pharmaceutical Industries Ltd. | 18.3% |
| Divi's Laboratories Ltd. | 8.9% |
| Apollo Hospitals Enterprise Ltd. | 8.0% |
| Cipla Ltd. | 7.2% |
| Max Healthcare Institute Ltd. | 7.1% |
| Torrent Pharmaceuticals Ltd. | 6.5% |
| Laurus Labs Ltd. | 6.1% |
| Dr. Reddy's Laboratories Ltd. | 6.1% |
| Lupin Ltd. | 5.1% |
| Fortis Healthcare Ltd. | 4.3% |
| Aurobindo Pharma Ltd. | 3.8% |
| Alkem Laboratories Ltd. | 2.9% |
| Glenmark Pharmaceuticals Ltd. | 2.9% |
| Biocon Ltd. | 2.6% |
| Zydus Lifesciences Ltd. | 2.4% |
| Mankind Pharma Ltd. | 2.4% |
| Ipca Laboratories Ltd. | 2.1% |
| Abbott India Ltd. | 1.3% |
| Piramal Pharma Ltd. | 1.1% |
| Syngene International Ltd. | 0.6% |
| Tri-Party Repo (TREPS) | 0.5% |
| Net Current Asset | -0.3% |
NameWeight
Sun Pharmaceutical Industries Ltd.18.3%
Divi's Laboratories Ltd.8.9%
Apollo Hospitals Enterprise Ltd.8.0%
Cipla Ltd.7.2%
Max Healthcare Institute Ltd.7.1%
Torrent Pharmaceuticals Ltd.6.5%
Laurus Labs Ltd.6.1%
Dr. Reddy's Laboratories Ltd.6.1%
Lupin Ltd.5.1%
Fortis Healthcare Ltd.4.3%
Aurobindo Pharma Ltd.3.8%
Alkem Laboratories Ltd.2.9%
Glenmark Pharmaceuticals Ltd.2.9%
Biocon Ltd.2.6%
Zydus Lifesciences Ltd.2.4%
Mankind Pharma Ltd.2.4%
Ipca Laboratories Ltd.2.1%
Abbott India Ltd.1.3%
Piramal Pharma Ltd.1.1%
Syngene International Ltd.0.6%
Tri-Party Repo (TREPS)0.5%
Net Current Asset-0.3%
Holdings Concentration
Total covered: 100%
Top 1–5
5 holdings
49.5%
49%
share
Top 6–10
5 holdings
28.1%
28%
share
Top 11–20
10 holdings
22.2%
22%
share
Beyond 20
1 holding
0.5%
0%
share
Market Cap Classification
Total
100%
allocation
- Mid Cap49.2%
- Large Cap48.9%
- Small Cap1.7%
- Mid Cap49.2%
- Large Cap48.9%
- Small Cap1.7%
Advanced Ratios
| Alpha | 0.00 |
| Beta | 1.00 |
| Sharpe Ratio | 0.05 |
| Sortino Ratio | 0.09 |
| Treynor Ratio | 0.04 |
| Information Ratio | 0.01 |
| Upside Capture | 99.87% |
| Downside Capture | 99.79% |
Index Methodology
| Factor Basis | Sector/Theme |
| What universe selected from? | Nifty 500 |
| Weightage? | Periodic Cappped Free-Float Market Cap Weighting, Max Weight per stock = 33%; Top 3 <62% |
| Stocks Included | Maximum 20 companies. Top 20 stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 20 based on Free Float market cap (Healthcare industry only) |
| Factor Basis | Sector/Theme |
| Universe | Nifty 500 |
| Weightage | Periodic Cappped Free-Float Market Cap Weighting, Max Weight per stock = 33%; Top 3 <62% |
| Stocks Included | Maximum 20 companies. Top 20 stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 20 based on Free Float market cap (Healthcare industry only) |
Fund • Last updated: 11/09/2026